Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VIVANZA.BOthis companyVivanza Biosciences Limited	₹1.45	17.6×	1.59×	0.06×	20.21×	-38453.8%	0.8%	0.6%	0.3%	9.0%	3.5%	-7.6%	2.34×	11.99×	2.55×	1.13×	0.0%	4	—	3	B
DECIPHER.BODecipher Labs Ltd.	₹5.60	-1.71×	0.26×	0.38×	-1.49×	-90.6%	95.4%	-27.8%	-21.9%	-14.9%	-15.4%	-44.0%	0.02×	0.07×	0×	5.22×	0.0%	3	—	2	C
HINDBIO.BOHindustan Bio Sciences Limited	₹6.70	-97.12×	9.28×	10.4×	-169.52×	-433.9%	10.1%	-10.6%	-10.7%	-9.6%	-2.5%	-1.8%	2.84×	-38.07×	-71.09×	38.8×	0.0%	1	—	1	D+
KOBO.BOKobo Biotech Ltd.	₹3.56	-1.92×	-0.07×	0×	-173.79×	-1982.9%	0.0%	0.0%	0.0%	3.7%	-2.1%	2.1%	-1.05×	-162.73×	-2,480×	0.23×	0.0%	3	—	—	—
NEXUSSURGL.BONexus Surgical and Medicare Limited	₹24.45	11.87×	4.86×	1.11×	8.55×	980.3%	64.8%	12.2%	9.4%	40.9%	39.7%	2.0%	0×	-0.52×	0×	1.96×	0.0%	4	7.52	2	C+
PATIDAR.BOPatidar Buildcon Limited	₹6.40	-19.74×	0.75×	13.68×	-81.72×	-96.7%	60.9%	-111.0%	-68.7%	-3.7%	-4.7%	10.0%	0.29×	-20.91×	-3.01×	1.96×	0.0%	3	—	2	C
Peer median	—	-1.92×	0.75×	1.11×	-81.72×	-96.7%	60.9%	-10.6%	-10.7%	-3.7%	-2.5%	2.0%	0.02×	-20.91×	-3.01×	1.96×	0.0%	3	7.52	2	—